Flow cytometric analysis of human peripheral blood leukocytes labelling Human GARP antibody at 1/200 dilution (1 μg) / (Right panel) compared with a Mouse IgG2b, κ Isotype Control / (Left panel). Goat Anti-Mouse IgG Alexa Fluor® 647 was used as the secondary antibody. Then cells were stained with CD41 - Alexa Fluor® 488 Antibody separately.
Product Details
Product Details
Product Specification
| Host | Mouse |
| Antigen | GARP |
| Synonyms | Transforming growth factor beta activator LRRC32; Garpin; Glycoprotein A repetitions predominant (GARP); Leucine-rich repeat-containing protein 32; D11S833E; LRRC32 |
| Location | Cell membrane |
| Accession | Q14392 |
| Clone Number | S-3497 |
| Antibody Type | Mouse mAb |
| Isotype | IgG2b,k |
| Application | FCM |
| Reactivity | Hu |
| Positive Sample | human peripheral blood leukocytes |
| Purification | Protein A |
| Concentration | 2 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS pH7.4 |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
| application | dilution | species |
| FCM | 1:200 | Hu |
Background
GARP, or Glycoprotein A Repetitions Predominant, is a transmembrane protein that acts as a critical docking receptor for latent TGF-β on the surface of activated regulatory T cells and platelets, where its 20 leucine-rich repeats form a horseshoe-shaped solenoid that both stabilizes the cytokine in an inactive conformation and licenses subsequent release through integrin-mediated deformation, thereby positioning GARP as a central checkpoint in immune tolerance and a prime therapeutic target in cancer, autoimmunity and fibrosis.
Picture
Picture
FC
